Myocardial strain for heart failure with preserved ejection fraction but without diastolic dysfunction

Jin Joo Park1, In-Chang Hwang1, Si-Hyuck Kang1

  • 1Cardiovascular Center and Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.

ESC Heart Failure
|July 13, 2022
PubMed

Insights

Patients with heart failure (HF) and preserved ejection fraction (HFpEF) but no diastolic dysfunction may have impaired myocardial strain. Impaired global longitudinal strain (GLS) indicates HF and predicts higher mortality.

Area of Science:

  • Cardiology
  • Cardiovascular Research
  • Heart Failure Research

Background:

  • Heart failure with preserved ejection fraction (HFpEF) presents diagnostic challenges, particularly when diastolic dysfunction is not significant.
  • Natriuretic peptides (NPs) and ejection fraction (EF) alone are insufficient for definitive HF diagnosis in some patients.
  • Myocardial strain analysis offers prognostic insights in cardiovascular conditions.

Purpose of the Study:

  • To investigate the prognostic value of global longitudinal strain (GLS) in patients with apparent heart failure (HF) and preserved ejection fraction (EF ≥50%) but without significant diastolic dysfunction.
  • To determine if impaired GLS identifies a subgroup of patients with HFpEF who have worse outcomes.
  • To compare the long-term survival of these patients with age- and sex-matched controls.

Main Methods:

  • Retrospective analysis of 355 patients with acute HF, EF ≥50%, elevated NPs, and no significant diastolic dysfunction.
  • Classification of patients into impaired GLS (<16%) and normal GLS (≥16%) groups.
  • Primary endpoint: 5-year all-cause mortality, compared between GLS groups and with controls.

Main Results:

  • Overall 5-year mortality was 30.1%.
  • Patients with impaired GLS (49.6%) had significantly higher 5-year mortality compared to those with normal GLS (P < 0.001).
  • Impaired GLS was associated with a 48% increased risk of all-cause mortality versus controls (HR 1.48).

Conclusions:

  • Impaired GLS identifies patients with apparent HF and preserved EF (without diastolic dysfunction) who have a worse prognosis.
  • Myocardial strain assessment, specifically GLS, is crucial for diagnosing and risk-stratifying patients with HFpEF.
  • Normal GLS in this cohort is associated with long-term survival comparable to the general population.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
31
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.5K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
46
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
27
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
20